Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications

in Journal of Endocrinology
Authors:
M Depreter
Search for other papers by M Depreter in
Current site
Google Scholar
PubMed
Close
,
J Vandesompele
Search for other papers by J Vandesompele in
Current site
Google Scholar
PubMed
Close
,
M Espeel
Search for other papers by M Espeel in
Current site
Google Scholar
PubMed
Close
,
F Speleman
Search for other papers by F Speleman in
Current site
Google Scholar
PubMed
Close
, and
F Roels
Search for other papers by F Roels in
Current site
Google Scholar
PubMed
Close
View More View Less
Free access

Peroxisomes are ubiquitous organelles required for several metabolic functions. Their dysfunction is responsible for a group of human inherited disorders. In the search for endogenous factors regulating the peroxisomal compartment in normal liver, we treated female rats with dehydroepiandrosterone (DHEA) and 25-hydroxycholecalciferol for 1 and 6 days. Relative transcription levels of 39 selected genes were evaluated by real-time quantitative RT-PCR analysis. Catalase (peroxisomal marker)-specific activity was assayed in total liver homogenate and peroxisomes were visualized by catalase localization. DHEA induced peroxisome proliferation and raised catalase specific activity. Expression levels of 16 (of which 11 were peroxisomal) genes were altered. Pex 11, acyl-CoA oxidase,l - andd -multifunctional enzyme, thiolase 1, phytanoyl-CoA hydroxylase, 70 kDa peroxisomal membrane protein and very long chain acyl-CoA synthetase were upregulated, three others were downregulated. Vitamin D caused downregulation of six genes. Administration of vitamin D to peroxisomal disorder patients may be contraindicated. The adrenocortical hormone DHEA is a potential natural regulator of the peroxisomal compartment. Its therapeutic use in X-linked adrenoleukodystrophy, some other beta-oxidation defects and classical Refsum should be considered.

 

  • Collapse
  • Expand